Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Esperion Therapeutics Inc

ESPR
Current price
2.73 USD +0.22 USD (+8.76%)
Last closed 2.5 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 474 597 312 USD
Yield for 12 month +83.22 %
1Y
3Y
5Y
10Y
15Y
ESPR
21.11.2021 - 28.11.2021

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. The company's products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. The company has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Address: 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.36 USD

P/E ratio

Dividend Yield

Current Year

+116 334 000 USD

Last Year

+75 475 000 USD

Current Quarter

+137 735 000 USD

Last Quarter

+32 250 000 USD

Current Year

+72 903 000 USD

Last Year

+48 508 000 USD

Current Quarter

+127 660 000 USD

Last Quarter

+20 792 000 USD

Key Figures ESPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -34 565 000 USD
Operating Margin TTM 52.47 %
PE Ratio
Return On Assets TTM -6.94 %
PEG Ratio -4.78
Return On Equity TTM -260.79 %
Wall Street Target Price 7.36 USD
Revenue TTM 229 740 000 USD
Book Value -1.57 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 466.1 %
Dividend Yield
Gross Profit TTM -70 419 000 USD
Earnings per share -0.9 USD
Diluted Eps TTM -0.9 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -37.65 %

Dividend Analytics ESPR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ESPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:6
Payout Ratio
Last Split Date 11.06.2013
Dividend Date

Stock Valuation ESPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 1.028
Enterprise Value Revenue 4.9851
Price Sales TTM 3.4041
Enterprise Value EBITDA -3.8634
Price Book MRQ 74.8863

Financials ESPR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ESPR

For 52 weeks

0.7 USD 3.4 USD
50 Day MA 2.37 USD
Shares Short Prior Month 24 887 802
200 Day MA 2.02 USD
Short Ratio 2.37
Shares Short 23 549 800
Short Percent 12.46 %

Dynamics of changes in the value of assets

G

GZUHF

0.11 USD Guangzhou R&F Properties Co. Ltd 0 (0%)
Detailed analytics
A

ADBKF

17.00 USD Addiko Bank AG 0 (0%)
Detailed analytics
0

0R7W

0.35 EUR Promotora de Informaciones SA +0 (+0.29%)
Detailed analytics
T

TJIPY

5.78 USD Tianjin Port Development Holdings Limited 0 (0%)
Detailed analytics
9

9666

6.28 HKD Jinke Smart Services Group Co Ltd +0.01 (+1.29%)
Detailed analytics